Leukotriene Receptor

白三烯受体 (cys-LTs) 是一类强效生物活性脂质,通过两种结构不同的 G 蛋白偶联受体(称为 CysLT1 和 CysLT2 受体)发挥作用。半胱氨酰白三烯 LTC4、LTD4 和 LTE4 是人类支气管哮喘的重要介质。白三烯受体是 G 蛋白偶联受体超家族的成员,使用磷脂酰肌醇-钙第二信使系统。LTD4 激活 CysLT1 会导致平滑肌收缩和增殖、水肿、嗜酸性粒细胞迁移和肺粘液层损伤。白三烯受体拮抗剂(简称 LTRA)是一类非甾体类口服药物。它们也可以称为抗炎支气管收缩预防剂。LTRA 通过阻断可能导致呼吸道炎症的化学反应发挥作用。

Leukotriene Receptor (cys-LTs) are a family of potent bioactive lipids that act through two structurally divergent G protein-coupled receptors, termed the CysLT1 and CysLT2 receptors. The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Leukotriene Receptor is a member of the superfamily of G protein-coupled receptors and uses a phosphatidylinositol-calcium second messenger system. Activation of CysLT1 by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung. Leukotriene receptor antagonists, called LTRAs for short, are a class of oral medication that is non-steroidal. They may also be referred to as anti-inflammatory bronchoconstriction preventors. LTRAs work by blocking a chemical reaction that can lead to inflammation in the airways.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
H-Ala-pNA

H-Ala-pNA 是一种 L-氨基酸对硝基苯胺 (pNA) 衍生物,是白三烯 A4 水解酶 (leukotriene A4 hydrolase) 的特异性底物,其 D 型对映体对该酶无活性,而 H-Ala-pNA 可被白三烯 A4 水解酶催化水解,通过分光光度法在 405 nm 下监测反应生成的对硝基苯胺即可实现对酶活性的定量检测,因此 H-Ala-pNA 已被用于评估针对白三烯 A4 水解酶的酰胺酶活性的抑制剂效能。

1668-13-9
Substrate
H-Ala-pNA

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础